Unknown

Dataset Information

0

Cracking the riddle of dedifferentiated liposarcoma: is EV-MDM2 a key?


ABSTRACT: Dedifferentiated liposarcoma (DDLPS) is molecularly characterized by wt p53 and MDM2 gene amplification causing MDM2 protein over-production, the key oncogenic process in DDLPS. Commonly located in fat-bearing retroperitoneal areas, almost 60% of DDLPS patients undergo multifocal recurrence, typically amenable to palliative treatment only, and occasionally develop distant metastasis. These factors lead to an abysmal 10% 10 year overall survival rate. Tumor cell-derived extracellular vesicles (EVs) can facilitate loco-regional malignancy dissemination by depositing molecular factors that participate in the development of pre-metastatic niches for tumor cell implantation and growth. High number of MDM2 DNA molecules was identified within EVs from DDLPS patient serum (ROC vs normal; 0.95) as well as from DDLPS cell lines. This MDM2 DNA could be transferred to preadipocytes (P-a), a major and ubiquitous cellular component of the DDLPS tumor microenvironment (TME), with subsequent P-a production of matrix metalloproteinase 2 (MMP2), a critical component in the metastatic cascade. From here the hypothesis that the DDLPS microenvironment (specifically P-a cells) may participate in DDLPS recurrence events. Since multifocal loco-regional DDLPS spreading is the main cause of the remarkably high lethality of this disease, a better understanding of the underlying oncogenic processes and their regulatory mechanisms is essential to improve the outcome of this devastating disease.

SUBMITTER: Casadei L 

PROVIDER: S-EPMC7105156 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cracking the riddle of dedifferentiated liposarcoma: is EV-MDM2 a key?

Casadei Lucia L   Pollock Raphael E RE  

Oncoscience 20200101 1-2


Dedifferentiated liposarcoma (DDLPS) is molecularly characterized by wt p53 and MDM2 gene amplification causing MDM2 protein over-production, the key oncogenic process in DDLPS. Commonly located in fat-bearing retroperitoneal areas, almost 60% of DDLPS patients undergo multifocal recurrence, typically amenable to palliative treatment only, and occasionally develop distant metastasis. These factors lead to an abysmal 10% 10 year overall survival rate. Tumor cell-derived extracellular vesicles (EV  ...[more]

Similar Datasets

| S-EPMC9684653 | biostudies-literature
| S-EPMC7463633 | biostudies-literature
| S-EPMC6774856 | biostudies-literature
| S-EPMC7589658 | biostudies-literature
| S-EPMC6779286 | biostudies-literature
| S-EPMC4775372 | biostudies-literature
| S-EPMC5483303 | biostudies-literature
| S-EPMC8730389 | biostudies-literature
| S-EPMC5481278 | biostudies-literature
| S-EPMC6676121 | biostudies-literature